In epidemiology, neuroimaging provides valuable insights into the prevalence, risk factors, and progression of neurological disorders. By allowing researchers to observe brain abnormalities and changes over time, it aids in identifying biomarkers for diseases such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis. This helps in the early diagnosis and development of targeted interventions.